People: Interleukin Genetics Inc (ILIU.PK)

ILIU.PK on OTC Markets Group

0.14USD
22 Oct 2014
Price Change (% chg)

-- (+0.07%)
Prev Close
$0.14
Open
$0.12
Day's High
$0.14
Day's Low
$0.12
Volume
1,765
Avg. Vol
16,586
52-wk High
$0.38
52-wk Low
$0.11

Search Stocks

Mills, William 

Brief Biography

Mr. William C. Mills, III, is Independent Director of Interleukin Genetics, Inc. He is currently an independent venture capitalist with over 30 years of experience in venture capital. From 2004 until 2009, Mr. Mills was a managing member of a management company conceived by EGS Healthcare Capital Partners to manage EGS Private Healthcare Partnership III. Earlier, Mr. Mills was a Partner in the Boston office of Advent International, a private equity and venture capital firm, for five years. At Advent, he was co-responsible for healthcare venture capital investments and focused on investments in the medical technology and biopharmaceutical sectors. Before joining Advent, Mr. Mills spent more than 11 years with the Venture Capital Fund of New England where he was a General Partner. Prior to that, he spent seven years at PaineWebber Ventures/Ampersand Ventures as Managing General Partner. Currently, he is a member of the Board of Managers of Ascension Health Ventures. Mr. Mills received his A.B. in Chemistry, cum laude, from Princeton University, his S.M. in Chemistry from the Massachusetts Institute of Technology and his M.S. in Management from MIT’s Sloan School of Management.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks